Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung...
Saved in:
Published in | Cancer letters Vol. 402; pp. 190 - 202 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
28.08.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma.
•miR-137 is a Slug-induced miRNA in lung cancer cells.•Knockdown of miR-137 abolishes Slug-induced cancer cell invasion and migration.•miR-137 functions as an oncogene in lung cancer.•Slug-induced miR-137 enhances lung cancer progression by direct targeting TFAP2C.•Our findings add new components to the Slug regulatory network in lung cancer. |
---|---|
AbstractList | The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma. The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma. •miR-137 is a Slug-induced miRNA in lung cancer cells.•Knockdown of miR-137 abolishes Slug-induced cancer cell invasion and migration.•miR-137 functions as an oncogene in lung cancer.•Slug-induced miR-137 enhances lung cancer progression by direct targeting TFAP2C.•Our findings add new components to the Slug regulatory network in lung cancer. The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma.The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma. Abstract The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma. |
Author | Tsai, Hsing-Chen Chen, Yen-Wei Chang, Yih-Leong Wu, Shang-Gin Kuo, Po-Yen Yu, Sung-Liang Liu, Yi-Nan Tsai, Meng-Feng Yang, Pan-Chyr Lin, Shih-Wen Gow, Chien-Hung Shih, Jin-Yuan Chang, Tzu-Hua |
Author_xml | – sequence: 1 givenname: Tzu-Hua surname: Chang fullname: Chang, Tzu-Hua organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 2 givenname: Meng-Feng surname: Tsai fullname: Tsai, Meng-Feng organization: Department of Molecular Biotechnology, Da-Yeh University, Changhua 51591, Taiwan – sequence: 3 givenname: Chien-Hung orcidid: 0000-0001-6104-3459 surname: Gow fullname: Gow, Chien-Hung organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 4 givenname: Shang-Gin surname: Wu fullname: Wu, Shang-Gin organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 5 givenname: Yi-Nan surname: Liu fullname: Liu, Yi-Nan organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 6 givenname: Yih-Leong surname: Chang fullname: Chang, Yih-Leong organization: Department of Pathology, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 7 givenname: Sung-Liang surname: Yu fullname: Yu, Sung-Liang organization: Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10002, Taiwan – sequence: 8 givenname: Hsing-Chen surname: Tsai fullname: Tsai, Hsing-Chen organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 9 givenname: Shih-Wen surname: Lin fullname: Lin, Shih-Wen organization: Graduate Institute of Oncology, National Taiwan University, Taipei 10002, Taiwan – sequence: 10 givenname: Yen-Wei orcidid: 0000-0002-8740-0351 surname: Chen fullname: Chen, Yen-Wei organization: Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10002, Taiwan – sequence: 11 givenname: Po-Yen surname: Kuo fullname: Kuo, Po-Yen organization: Department of Pathology, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin 64041, Taiwan – sequence: 12 givenname: Pan-Chyr surname: Yang fullname: Yang, Pan-Chyr organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan – sequence: 13 givenname: Jin-Yuan surname: Shih fullname: Shih, Jin-Yuan email: jyshih@ntu.edu.tw organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28610956$$D View this record in MEDLINE/PubMed |
BookMark | eNqVUtFqFDEUDVKx2-ofiAR88WXWm8kkkxERlsWqUFRs-xyymTvbrDOTNZkp7p_4uWZ2W4WCFCEkIfeck5tzckKOet8jIc8ZzBkw-Xozt6ZvcZjnwMo5yDlA_ojMmCrzrKwUHJEZcCgyrrg4JicxbgBAFKV4Qo5zJRlUQs7Ir6ttwPXYmsH5nvqGds4G_-3zImO8pPgzVWOcSqsdvWjHNd0G3_kBIx3Gzgfq-huzr5u-ph0OJqbh4qSU-s1iZ9qWWkxTO_Zrmlq2GPYHSeE6-HF9TeO4_XNN4l2eLb7my6fkcWPaiM9u11Nydfb-cvkxO__y4dNycZ5ZIYshq21jK9PkysgKmhzRQIMNglSlWYlaqaYuqpUVmKe9wbrMa8kFM7IRKpmw4qfk1UE3PezHiHHQnYtTf6ZHP0bNKqjKQgrOE_TlPejGj6FP3SUUq4pCcKES6sUtalx1WOttcJ0JO33neQK8OQCS0TEGbLR1w97_IRjXagZ6Clhv9CFgPQWsQeoUcCIX98h3-g_Q3h1omKy8cRh0tA5TFrULaAdde_e_ArZ1vbOm_Y47jH-N0DHXoC-mrzf9PFZy4KWaXv323wIP3_8bqj3s9Q |
CitedBy_id | crossref_primary_10_1016_j_snb_2024_135421 crossref_primary_10_2131_jts_43_281 crossref_primary_10_3389_fcell_2024_1427724 crossref_primary_10_3892_ijmm_2017_3187 crossref_primary_10_1016_j_aca_2023_341990 crossref_primary_10_3390_cancers14194809 crossref_primary_10_3892_ol_2018_9739 crossref_primary_10_1016_j_bbadis_2018_01_020 crossref_primary_10_3389_fimmu_2024_1464327 crossref_primary_10_3727_096504018X15195193936573 crossref_primary_10_3892_ol_2018_9559 crossref_primary_10_3390_biology10111200 crossref_primary_10_1186_s13046_022_02452_9 crossref_primary_10_1007_s12668_021_00921_7 crossref_primary_10_1016_j_heliyon_2023_e15725 crossref_primary_10_1016_j_omtn_2020_09_015 crossref_primary_10_3892_ijo_2023_5544 crossref_primary_10_3892_ol_2019_10478 crossref_primary_10_3390_ncrna4020014 crossref_primary_10_1177_1758835919850665 crossref_primary_10_1038_s41388_020_1228_1 crossref_primary_10_3390_cancers11020265 crossref_primary_10_1002_mgg3_1126 crossref_primary_10_1016_j_omtn_2018_08_020 crossref_primary_10_1042_BSR20181928 crossref_primary_10_1158_1541_7786_MCR_19_0359 crossref_primary_10_1186_s13046_019_1105_3 crossref_primary_10_18632_oncotarget_21954 crossref_primary_10_1186_s13046_018_0807_2 crossref_primary_10_1016_j_yexmp_2020_104411 crossref_primary_10_3390_molecules26195804 crossref_primary_10_1016_j_yexcr_2019_03_035 crossref_primary_10_1016_j_omtn_2020_06_028 crossref_primary_10_1016_j_prp_2022_154053 crossref_primary_10_1073_pnas_1913307116 crossref_primary_10_3390_cells12040667 crossref_primary_10_1016_j_jpba_2018_10_017 crossref_primary_10_1038_s41398_024_03175_5 crossref_primary_10_1177_2045894020951759 crossref_primary_10_3390_cancers12010209 crossref_primary_10_3389_fgene_2020_01023 crossref_primary_10_1186_s13046_018_0739_x crossref_primary_10_1002_mc_23505 crossref_primary_10_3389_fendo_2022_930227 crossref_primary_10_1002_jcp_27855 |
Cites_doi | 10.1245/ASO.2005.04.010 10.1038/sj.onc.1209091 10.1038/sj.bjc.6603193 10.1016/j.ccr.2007.12.008 10.1038/emboj.2011.102 10.1007/s13277-015-4611-8 10.1002/ijc.25452 10.1126/science.7513443 10.1186/s13578-015-0028-8 10.1038/nrm2868 10.1164/rccm.201009-1440OC 10.1124/pr.54.1.129 10.1038/ncomms2876 10.1093/carcin/bgr110 10.1038/onc.2010.215 10.1186/1476-4598-10-139 10.1186/1477-7819-11-12 10.3892/ol.2012.1026 10.3109/1061186X.2015.1057149 10.1038/onc.2015.59 10.1371/journal.pone.0096765 10.1128/MCB.01228-12 10.1186/2052-8426-2-7 10.1038/onc.2014.58 10.1038/sj.onc.1209534 10.3892/or.2016.4604 10.1093/nar/gkp803 10.1016/j.cell.2009.11.007 10.1016/j.cell.2005.09.029 10.1158/1078-0432.CCR-09-2638 10.1242/dev.061762 10.1007/s12094-015-1357-0 10.1371/journal.pone.0109734 10.1158/1078-0432.CCR-10-0230 10.18632/oncotarget.3943 10.1038/cddis.2013.144 10.1016/j.semcancer.2012.02.013 10.1158/1078-0432.CCR-05-0687 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. Copyright Elsevier Limited Aug 28, 2017 |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. – notice: Copyright Elsevier Limited Aug 28, 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U9 H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.canlet.2017.06.002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-7980 |
EndPage | 202 |
ExternalDocumentID | 28610956 10_1016_j_canlet_2017_06_002 S0304383517303786 1_s2_0_S0304383517303786 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 4.4 457 4CK 4G. 5GY 5RE 5VS 6J9 6PF 7-5 71M 8FE 8FH 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABMAC ABMZM ABUDA ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IH2 IHE J1W K-O KOM LK8 M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 ROL RPZ SCC SDF SDG SDP SEL SES SPCBC SSH SSU SSZ T5K Z5R ~G- .55 .GJ 3O- 3V. 53G 7RV 7X7 8C1 8FI AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO AFCTW AFFNX AFJKZ AFKRA AFKWA AGRDE AI. AJOXV AMFUW ASPBG AVWKF AZFZN AZQEC BBNVY BENPR BHPHI FEDTE FGOYB FYUFA G-2 GUQSH HCIFZ HED HMK HMO HVGLF HZ~ M1P M2M M2O M7P R2- RIG SAE SEW UDS VH1 WUQ X7M ZGI AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX AGQPQ AGRNS AIGII CITATION CGR CUY CVF ECM EIF NPM 7TO 7U9 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c564t-dcfc9af28a690f2eea0fefe0687ab5d88fd49bc5e2d88aed72d6351a6f58861b3 |
IEDL.DBID | .~1 |
ISSN | 0304-3835 1872-7980 |
IngestDate | Mon Jul 21 10:47:42 EDT 2025 Wed Aug 13 06:47:34 EDT 2025 Wed Feb 19 02:36:09 EST 2025 Tue Jul 01 02:29:34 EDT 2025 Thu Apr 24 23:09:44 EDT 2025 Fri Feb 23 02:33:48 EST 2024 Tue Feb 25 20:00:34 EST 2025 Tue Aug 26 17:11:33 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Epithelial-mesenchymal transition (EMT) miR-137 TFAP2C Slug Non-small cell lung cancer (NSCLC) |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-dcfc9af28a690f2eea0fefe0687ab5d88fd49bc5e2d88aed72d6351a6f58861b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6104-3459 0000-0002-8740-0351 |
PMID | 28610956 |
PQID | 1919445358 |
PQPubID | 2031080 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1909746533 proquest_journals_1919445358 pubmed_primary_28610956 crossref_citationtrail_10_1016_j_canlet_2017_06_002 crossref_primary_10_1016_j_canlet_2017_06_002 elsevier_sciencedirect_doi_10_1016_j_canlet_2017_06_002 elsevier_clinicalkeyesjournals_1_s2_0_S0304383517303786 elsevier_clinicalkey_doi_10_1016_j_canlet_2017_06_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-08-28 |
PublicationDateYYYYMMDD | 2017-08-28 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland – name: Clare |
PublicationTitle | Cancer letters |
PublicationTitleAlternate | Cancer Lett |
PublicationYear | 2017 |
Publisher | Elsevier B.V Elsevier Limited |
Publisher_xml | – name: Elsevier B.V – name: Elsevier Limited |
References | Liu, Lang, Qiu, Xu, Li, Tang (bib35) 2011; 128 Li, Zhang, Wang, Wang (bib36) 2016; 24 Wang, Yue, Yu, Wang, Wang (bib17) 2013; 11 Penna, Orso, Cimino, Tenaglia, Lembo, Quaglino (bib42) 2011; 30 Thiery, Acloque, Huang, Nieto (bib2) 2009; 139 Zaravinos (bib21) 2015; 2015 Tian, Zhang, Hurd, Hannenhalli, Liu, Lu (bib31) 2011; 138 Xiu, Liu, Xia, Jin, Yin, Zhao (bib37) 2014; 9 Bishop, Benjamin, Cholakh, Chajut, Clark, Westra (bib23) 2010; 16 Martin, Goyal, Watkins, Jiang (bib11) 2005; 12 Wang, Hsiao, Hong, Chen, Kao, Wang (bib25) 2014; 9 Wang, Huang, Kao, Hsu, Wang, Li (bib16) 2015; 34 Dong, Jin, Li, Ren, Liu (bib33) 2016; 35 Shih, Yang (bib3) 2011; 32 Schrem, Klempnauer, Borlak (bib29) 2002; 54 Tiwari, Gheldof, Tatari, Christofori (bib4) 2012; 22 Zhou, Liu, Wang, Ouyang (bib19) 2015; 5 Yu, Chen, Chang, Chen, Chen, Singh (bib22) 2008; 13 Wu, Heinrichs, Xu, Garrison, Zambetti, Adams (bib28) 2005; 123 Prislei, Martinelli, Zannoni, Petrillo, Filippetti, Mariani (bib8) 2015; 6 Merikallio, T, Pääkkö, Mäkitaro, Kaarteenaho, Lehtonen (bib27) 2014; 7 Lin, Chang, Chang, Lin, Chen, Pan (bib24) 2013; 4 Rothschild (bib32) 2014; 2 Shih, Tsai, Chang, Chang, Yuan, Yu (bib5) 2005; 11 Li, Watts, Oshiro, Futscher, Domann (bib41) 2006; 25 Kumar, Luo, Tudela, Alexander, Mendelson (bib30) 2013; 33 Park, Wu, Cyr, Woodfield, De Andrade, Spanheimer (bib40) 2015; 34 Nieto, Sargent, Wilkinson, Cooke (bib10) 1994; 64 Shioiri, Shida, Koda, Oda, Seike, Nishimura (bib12) 2006; 94 Yang, Li, Gao, Zhao, Zang, Zhang (bib38) 2015; 8 Norozi, Ahmadzadeh, Shahjahani, Shahrabi, Saki (bib9) 2016; 18 Zhang, Zhou, Tian, Liu, Xia (bib7) 2013; 5 Inui, Martello, Piccolo (bib20) 2010; 11 Wang, Lu, Qiu, Cui (bib26) 2010; 38 Su, Ku, Chen, Hsu, Hong, Chang (bib39) 2016; 6 Uygur, Wu (bib13) 2011; 10 Tirino, Camerlingo, Bifulco, Irollo, Montella, Paino (bib15) 2013; 4 Luo, Li, Dong, Sun (bib34) 2016; 37 Kosaka, Kikuchi, Mikami, Miyajima, Shirotake, Ishida (bib6) 2010; 16 Larue, Bellacosa (bib1) 2005; 20 Singh, Settleman (bib14) 2010; 29 Chang, Tsai, Su, Wu, Huang, Yu (bib18) 2011; 183 Shih (10.1016/j.canlet.2017.06.002_bib5) 2005; 11 Wu (10.1016/j.canlet.2017.06.002_bib28) 2005; 123 Inui (10.1016/j.canlet.2017.06.002_bib20) 2010; 11 Thiery (10.1016/j.canlet.2017.06.002_bib2) 2009; 139 Tian (10.1016/j.canlet.2017.06.002_bib31) 2011; 138 Norozi (10.1016/j.canlet.2017.06.002_bib9) 2016; 18 Nieto (10.1016/j.canlet.2017.06.002_bib10) 1994; 64 Uygur (10.1016/j.canlet.2017.06.002_bib13) 2011; 10 Dong (10.1016/j.canlet.2017.06.002_bib33) 2016; 35 Yu (10.1016/j.canlet.2017.06.002_bib22) 2008; 13 Park (10.1016/j.canlet.2017.06.002_bib40) 2015; 34 Kosaka (10.1016/j.canlet.2017.06.002_bib6) 2010; 16 Yang (10.1016/j.canlet.2017.06.002_bib38) 2015; 8 Larue (10.1016/j.canlet.2017.06.002_bib1) 2005; 20 Merikallio (10.1016/j.canlet.2017.06.002_bib27) 2014; 7 Schrem (10.1016/j.canlet.2017.06.002_bib29) 2002; 54 Zhang (10.1016/j.canlet.2017.06.002_bib7) 2013; 5 Wang (10.1016/j.canlet.2017.06.002_bib25) 2014; 9 Rothschild (10.1016/j.canlet.2017.06.002_bib32) 2014; 2 Kumar (10.1016/j.canlet.2017.06.002_bib30) 2013; 33 Shih (10.1016/j.canlet.2017.06.002_bib3) 2011; 32 Bishop (10.1016/j.canlet.2017.06.002_bib23) 2010; 16 Zhou (10.1016/j.canlet.2017.06.002_bib19) 2015; 5 Prislei (10.1016/j.canlet.2017.06.002_bib8) 2015; 6 Li (10.1016/j.canlet.2017.06.002_bib36) 2016; 24 Shioiri (10.1016/j.canlet.2017.06.002_bib12) 2006; 94 Luo (10.1016/j.canlet.2017.06.002_bib34) 2016; 37 Xiu (10.1016/j.canlet.2017.06.002_bib37) 2014; 9 Li (10.1016/j.canlet.2017.06.002_bib41) 2006; 25 Chang (10.1016/j.canlet.2017.06.002_bib18) 2011; 183 Liu (10.1016/j.canlet.2017.06.002_bib35) 2011; 128 Tirino (10.1016/j.canlet.2017.06.002_bib15) 2013; 4 Wang (10.1016/j.canlet.2017.06.002_bib17) 2013; 11 Singh (10.1016/j.canlet.2017.06.002_bib14) 2010; 29 Wang (10.1016/j.canlet.2017.06.002_bib26) 2010; 38 Zaravinos (10.1016/j.canlet.2017.06.002_bib21) 2015; 2015 Tiwari (10.1016/j.canlet.2017.06.002_bib4) 2012; 22 Penna (10.1016/j.canlet.2017.06.002_bib42) 2011; 30 Su (10.1016/j.canlet.2017.06.002_bib39) 2016; 6 Wang (10.1016/j.canlet.2017.06.002_bib16) 2015; 34 Lin (10.1016/j.canlet.2017.06.002_bib24) 2013; 4 Martin (10.1016/j.canlet.2017.06.002_bib11) 2005; 12 |
References_xml | – volume: 183 start-page: 1071 year: 2011 end-page: 1079 ident: bib18 article-title: Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor publication-title: Am. J. Respir. Crit. Care Med. – volume: 38 start-page: D119 year: 2010 end-page: D122 ident: bib26 article-title: TransmiR: a transcription factor-microRNA regulation database publication-title: Nucleic Acids Res. – volume: 7 start-page: 5846 year: 2014 end-page: 5854 ident: bib27 article-title: Slug is associated with poor survival in squamous cell carcinoma of the lung publication-title: Int. J. Clin. Exp. Pathol. – volume: 6 start-page: 18966 year: 2015 end-page: 18979 ident: bib8 article-title: Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer publication-title: Oncotarget – volume: 24 start-page: 102 year: 2016 end-page: 110 ident: bib36 article-title: MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6 publication-title: J. Drug Target – volume: 9 start-page: e96765 year: 2014 ident: bib25 article-title: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma publication-title: PLoS One – volume: 18 start-page: 113 year: 2016 end-page: 124 ident: bib9 article-title: Twist as a new prognostic marker in hematological malignancies publication-title: Clin. Transl. Oncol. – volume: 34 start-page: 1116 year: 2015 end-page: 1125 ident: bib16 article-title: Slug is temporally regulated by cyclin E in cell cycle and controls genome stability publication-title: Oncogene – volume: 128 start-page: 1269 year: 2011 end-page: 1279 ident: bib35 article-title: miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells publication-title: Int. J. Cancer – volume: 13 start-page: 48 year: 2008 end-page: 57 ident: bib22 article-title: MicroRNA signature predicts survival and relapse in lung cancer publication-title: Cancer Cell – volume: 30 start-page: 1990 year: 2011 end-page: 2007 ident: bib42 article-title: microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C publication-title: EMBO J. – volume: 139 start-page: 871 year: 2009 end-page: 890 ident: bib2 article-title: Epithelial–mesenchymal transitions in development and disease publication-title: Cell – volume: 123 start-page: 641 year: 2005 end-page: 653 ident: bib28 article-title: Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma publication-title: Cell – volume: 11 start-page: 12 year: 2013 ident: bib17 article-title: SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis publication-title: World J. Surg. Oncol. – volume: 6 start-page: 1317 year: 2016 end-page: 1330 ident: bib39 article-title: Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma publication-title: Am. J. Cancer Res. – volume: 2 start-page: 7 year: 2014 ident: bib32 article-title: microRNA therapies in cancer publication-title: Mol. Cell Ther. – volume: 8 start-page: 10847 year: 2015 end-page: 10853 ident: bib38 article-title: MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells publication-title: Int. J. Clin. Exp. Pathol. – volume: 2015 start-page: 865816 year: 2015 ident: bib21 article-title: The regulatory role of MicroRNAs in EMT and cancer publication-title: J. Oncol. – volume: 25 start-page: 5405 year: 2006 end-page: 5415 ident: bib41 article-title: AP-2 alpha and AP-2 gamma are transcriptional targets of p53 in human breast carcinoma cells publication-title: Oncogene – volume: 29 start-page: 4741 year: 2010 end-page: 4751 ident: bib14 article-title: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer publication-title: Oncogene – volume: 5 start-page: 32 year: 2015 ident: bib19 article-title: The roles of microRNAs in the regulation of tumor metastasis publication-title: Cell Biosci. – volume: 16 start-page: 610 year: 2010 end-page: 619 ident: bib23 article-title: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach publication-title: Clin. Cancer Res. – volume: 4 start-page: 1877 year: 2013 ident: bib24 article-title: MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 publication-title: Nat. Commun. – volume: 16 start-page: 5814 year: 2010 end-page: 5823 ident: bib6 article-title: Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion publication-title: Clin. Cancer Res. – volume: 4 start-page: e620 year: 2013 ident: bib15 article-title: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction publication-title: Cell Death Dis. – volume: 11 start-page: 252 year: 2010 end-page: 263 ident: bib20 article-title: MicroRNA control of signal transduction publication-title: Nat. Rev. Mol. Cell Biol. – volume: 20 start-page: 7443 year: 2005 end-page: 7454 ident: bib1 article-title: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways publication-title: Oncogene – volume: 138 start-page: 1235 year: 2011 end-page: 1245 ident: bib31 article-title: Regulation of lung endoderm progenitor cell behavior by miR302/367 publication-title: Development – volume: 64 start-page: 835 year: 1994 end-page: 839 ident: bib10 article-title: Control of cell behavior during vertebrate development by Slug, a zinc finger gene publication-title: Science – volume: 37 start-page: 7749 year: 2016 end-page: 7755 ident: bib34 article-title: microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR publication-title: Tumour Biol. – volume: 12 start-page: 488 year: 2005 end-page: 496 ident: bib11 article-title: Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer publication-title: Ann. Surg. Oncol. – volume: 34 start-page: 6105 year: 2015 end-page: 6114 ident: bib40 article-title: The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis publication-title: Oncogene – volume: 11 start-page: 8070 year: 2005 end-page: 8078 ident: bib5 article-title: Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma publication-title: Clin. Cancer Res. – volume: 32 start-page: 1299 year: 2011 end-page: 1304 ident: bib3 article-title: The EMT regulator slug and lung carcinogenesis publication-title: Carcinogenesis – volume: 5 start-page: 564 year: 2013 end-page: 568 ident: bib7 article-title: High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer publication-title: Oncol. Lett. – volume: 35 start-page: 2151 year: 2016 end-page: 2158 ident: bib33 article-title: miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12 publication-title: Oncol. Rep. – volume: 9 start-page: e109734 year: 2014 ident: bib37 article-title: MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3 publication-title: PLoS One – volume: 22 start-page: 194 year: 2012 end-page: 207 ident: bib4 article-title: EMT as the ultimate survival mechanism of cancer cells publication-title: Semin. Cancer Biol. – volume: 94 start-page: 1816 year: 2006 end-page: 1822 ident: bib12 article-title: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients publication-title: Br. J. Cancer – volume: 10 start-page: 139 year: 2011 ident: bib13 article-title: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis publication-title: Mol. Cancer – volume: 54 start-page: 129 year: 2002 end-page: 158 ident: bib29 article-title: Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression publication-title: Pharmacol. Rev. – volume: 33 start-page: 1782 year: 2013 end-page: 1796 ident: bib30 article-title: The c-Myc-regulated microRNA-17∼92 (miR-17∼92) and miR-106a∼363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation publication-title: Mol. Cell Biol. – volume: 12 start-page: 488 year: 2005 ident: 10.1016/j.canlet.2017.06.002_bib11 article-title: Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer publication-title: Ann. Surg. Oncol. doi: 10.1245/ASO.2005.04.010 – volume: 20 start-page: 7443 year: 2005 ident: 10.1016/j.canlet.2017.06.002_bib1 article-title: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways publication-title: Oncogene doi: 10.1038/sj.onc.1209091 – volume: 94 start-page: 1816 year: 2006 ident: 10.1016/j.canlet.2017.06.002_bib12 article-title: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6603193 – volume: 13 start-page: 48 year: 2008 ident: 10.1016/j.canlet.2017.06.002_bib22 article-title: MicroRNA signature predicts survival and relapse in lung cancer publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.12.008 – volume: 30 start-page: 1990 year: 2011 ident: 10.1016/j.canlet.2017.06.002_bib42 article-title: microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C publication-title: EMBO J. doi: 10.1038/emboj.2011.102 – volume: 37 start-page: 7749 year: 2016 ident: 10.1016/j.canlet.2017.06.002_bib34 article-title: microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR publication-title: Tumour Biol. doi: 10.1007/s13277-015-4611-8 – volume: 8 start-page: 10847 year: 2015 ident: 10.1016/j.canlet.2017.06.002_bib38 article-title: MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells publication-title: Int. J. Clin. Exp. Pathol. – volume: 128 start-page: 1269 year: 2011 ident: 10.1016/j.canlet.2017.06.002_bib35 article-title: miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells publication-title: Int. J. Cancer doi: 10.1002/ijc.25452 – volume: 7 start-page: 5846 year: 2014 ident: 10.1016/j.canlet.2017.06.002_bib27 article-title: Slug is associated with poor survival in squamous cell carcinoma of the lung publication-title: Int. J. Clin. Exp. Pathol. – volume: 64 start-page: 835 year: 1994 ident: 10.1016/j.canlet.2017.06.002_bib10 article-title: Control of cell behavior during vertebrate development by Slug, a zinc finger gene publication-title: Science doi: 10.1126/science.7513443 – volume: 5 start-page: 32 year: 2015 ident: 10.1016/j.canlet.2017.06.002_bib19 article-title: The roles of microRNAs in the regulation of tumor metastasis publication-title: Cell Biosci. doi: 10.1186/s13578-015-0028-8 – volume: 11 start-page: 252 year: 2010 ident: 10.1016/j.canlet.2017.06.002_bib20 article-title: MicroRNA control of signal transduction publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2868 – volume: 183 start-page: 1071 year: 2011 ident: 10.1016/j.canlet.2017.06.002_bib18 article-title: Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.201009-1440OC – volume: 54 start-page: 129 year: 2002 ident: 10.1016/j.canlet.2017.06.002_bib29 article-title: Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression publication-title: Pharmacol. Rev. doi: 10.1124/pr.54.1.129 – volume: 6 start-page: 1317 year: 2016 ident: 10.1016/j.canlet.2017.06.002_bib39 article-title: Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma publication-title: Am. J. Cancer Res. – volume: 4 start-page: 1877 year: 2013 ident: 10.1016/j.canlet.2017.06.002_bib24 article-title: MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 publication-title: Nat. Commun. doi: 10.1038/ncomms2876 – volume: 32 start-page: 1299 year: 2011 ident: 10.1016/j.canlet.2017.06.002_bib3 article-title: The EMT regulator slug and lung carcinogenesis publication-title: Carcinogenesis doi: 10.1093/carcin/bgr110 – volume: 29 start-page: 4741 year: 2010 ident: 10.1016/j.canlet.2017.06.002_bib14 article-title: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer publication-title: Oncogene doi: 10.1038/onc.2010.215 – volume: 10 start-page: 139 year: 2011 ident: 10.1016/j.canlet.2017.06.002_bib13 article-title: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis publication-title: Mol. Cancer doi: 10.1186/1476-4598-10-139 – volume: 11 start-page: 12 year: 2013 ident: 10.1016/j.canlet.2017.06.002_bib17 article-title: SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis publication-title: World J. Surg. Oncol. doi: 10.1186/1477-7819-11-12 – volume: 5 start-page: 564 year: 2013 ident: 10.1016/j.canlet.2017.06.002_bib7 article-title: High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer publication-title: Oncol. Lett. doi: 10.3892/ol.2012.1026 – volume: 24 start-page: 102 year: 2016 ident: 10.1016/j.canlet.2017.06.002_bib36 article-title: MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6 publication-title: J. Drug Target doi: 10.3109/1061186X.2015.1057149 – volume: 34 start-page: 6105 year: 2015 ident: 10.1016/j.canlet.2017.06.002_bib40 article-title: The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis publication-title: Oncogene doi: 10.1038/onc.2015.59 – volume: 9 start-page: e96765 year: 2014 ident: 10.1016/j.canlet.2017.06.002_bib25 article-title: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma publication-title: PLoS One doi: 10.1371/journal.pone.0096765 – volume: 33 start-page: 1782 year: 2013 ident: 10.1016/j.canlet.2017.06.002_bib30 article-title: The c-Myc-regulated microRNA-17∼92 (miR-17∼92) and miR-106a∼363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation publication-title: Mol. Cell Biol. doi: 10.1128/MCB.01228-12 – volume: 2 start-page: 7 year: 2014 ident: 10.1016/j.canlet.2017.06.002_bib32 article-title: microRNA therapies in cancer publication-title: Mol. Cell Ther. doi: 10.1186/2052-8426-2-7 – volume: 2015 start-page: 865816 year: 2015 ident: 10.1016/j.canlet.2017.06.002_bib21 article-title: The regulatory role of MicroRNAs in EMT and cancer publication-title: J. Oncol. – volume: 34 start-page: 1116 year: 2015 ident: 10.1016/j.canlet.2017.06.002_bib16 article-title: Slug is temporally regulated by cyclin E in cell cycle and controls genome stability publication-title: Oncogene doi: 10.1038/onc.2014.58 – volume: 25 start-page: 5405 year: 2006 ident: 10.1016/j.canlet.2017.06.002_bib41 article-title: AP-2 alpha and AP-2 gamma are transcriptional targets of p53 in human breast carcinoma cells publication-title: Oncogene doi: 10.1038/sj.onc.1209534 – volume: 35 start-page: 2151 year: 2016 ident: 10.1016/j.canlet.2017.06.002_bib33 article-title: miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12 publication-title: Oncol. Rep. doi: 10.3892/or.2016.4604 – volume: 38 start-page: D119 year: 2010 ident: 10.1016/j.canlet.2017.06.002_bib26 article-title: TransmiR: a transcription factor-microRNA regulation database publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkp803 – volume: 139 start-page: 871 year: 2009 ident: 10.1016/j.canlet.2017.06.002_bib2 article-title: Epithelial–mesenchymal transitions in development and disease publication-title: Cell doi: 10.1016/j.cell.2009.11.007 – volume: 123 start-page: 641 year: 2005 ident: 10.1016/j.canlet.2017.06.002_bib28 article-title: Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma publication-title: Cell doi: 10.1016/j.cell.2005.09.029 – volume: 16 start-page: 610 year: 2010 ident: 10.1016/j.canlet.2017.06.002_bib23 article-title: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-09-2638 – volume: 138 start-page: 1235 year: 2011 ident: 10.1016/j.canlet.2017.06.002_bib31 article-title: Regulation of lung endoderm progenitor cell behavior by miR302/367 publication-title: Development doi: 10.1242/dev.061762 – volume: 18 start-page: 113 year: 2016 ident: 10.1016/j.canlet.2017.06.002_bib9 article-title: Twist as a new prognostic marker in hematological malignancies publication-title: Clin. Transl. Oncol. doi: 10.1007/s12094-015-1357-0 – volume: 9 start-page: e109734 year: 2014 ident: 10.1016/j.canlet.2017.06.002_bib37 article-title: MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3 publication-title: PLoS One doi: 10.1371/journal.pone.0109734 – volume: 16 start-page: 5814 year: 2010 ident: 10.1016/j.canlet.2017.06.002_bib6 article-title: Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-0230 – volume: 6 start-page: 18966 year: 2015 ident: 10.1016/j.canlet.2017.06.002_bib8 article-title: Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer publication-title: Oncotarget doi: 10.18632/oncotarget.3943 – volume: 4 start-page: e620 year: 2013 ident: 10.1016/j.canlet.2017.06.002_bib15 article-title: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction publication-title: Cell Death Dis. doi: 10.1038/cddis.2013.144 – volume: 22 start-page: 194 year: 2012 ident: 10.1016/j.canlet.2017.06.002_bib4 article-title: EMT as the ultimate survival mechanism of cancer cells publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2012.02.013 – volume: 11 start-page: 8070 year: 2005 ident: 10.1016/j.canlet.2017.06.002_bib5 article-title: Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-05-0687 |
SSID | ssj0005475 |
Score | 2.440699 |
Snippet | The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and... Abstract The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 190 |
SubjectTerms | 3' Untranslated Regions Adenocarcinoma Adenocarcinoma - genetics Adenocarcinoma - metabolism Adenocarcinoma - mortality Adenocarcinoma - secondary Adenocarcinoma of Lung Animals Antineoplastic Agents - pharmacology Apoptosis Arrays Binding Sites Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - secondary Cell cycle Cell growth Cell Line, Tumor Cell Movement - drug effects Cisplatin - pharmacology Epithelial-mesenchymal transition (EMT) Gene expression Gene Expression Regulation, Neoplastic Hematology, Oncology and Palliative Medicine Humans Kaplan-Meier Estimate Kinases Lung cancer Lung Neoplasms - genetics Lung Neoplasms - metabolism Lung Neoplasms - mortality Lung Neoplasms - pathology Male Medical prognosis Mesenchyme Metastases Metastasis Mice, Inbred NOD Mice, SCID MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism miR-137 miRNA Neoplasm Invasiveness Non-small cell lung cancer (NSCLC) Non-small cell lung carcinoma Promoter Regions, Genetic Protein Binding RNA Interference Signal Transduction Slug Snail Family Transcription Factors - genetics Snail Family Transcription Factors - metabolism Survival TFAP2C Thyroid cancer Time Factors Transcription Factor AP-2 - genetics Transcription Factor AP-2 - metabolism Transcription factors Transfection Up-Regulation |
Title | Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0304383517303786 https://www.clinicalkey.es/playcontent/1-s2.0-S0304383517303786 https://dx.doi.org/10.1016/j.canlet.2017.06.002 https://www.ncbi.nlm.nih.gov/pubmed/28610956 https://www.proquest.com/docview/1919445358 https://www.proquest.com/docview/1909746533 |
Volume | 402 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_HCeKL-O3qeUTwtW4_kiZ9XBaXVblFvFu4t5C2E1npdsu2FX3x7_DPdZKm64knJ761TSYJM9PJTPLLhJBXphC8RNUJ7FYJBiiCB1lueICTIcZbhieFw-acrdLlmr275JdHZD6ehbGwSm_7B5vurLX_MvXcnDabzfTcbuphfMUjVNJESJt2mzFhtfz19yswD-aS7drKga09Hp9zGC8cPXLHAryEy-LpF1eumZ7-5n66aWhxj9z1_iOdDUO8T46gfkBun_kd8ofkx7rZD9fLI8PpztCtRdx9XM2QTYLCV497rWn-jZ5X_SfaODwetLTrt7s93dRftCvXdUm30Gn0HttNa1uqd3XQbnVVUbvaTys0E7SwSrN3H7CF4c4f2vbNoRuku1jMPsTzR2S9eHMxXwb-9oWg4CnrgrIwRaZNLDUG0CYG0KEBA2Eqhc55iYIsWZYXHGJ81lCKuETnJdKp4VKmUZ48Jsc4MHhKKA9DEJKnmiUY7oDMRWoyKRgkgA3nMCHJyHRV-NTk9oaMSo0YtM9qEJWyolIOihdPSHCgaobUHDfU56M81XjsFA2lwrnjBjpxHR20_m9vVaTaWIXqD428SvmbUv9Dnyejwqlf3WRRxhhPuJyQl4diNAdWyLqGXW_rhBghpujET8iTQVEPzImlza3P02f_Pazn5I59s2vqsTwhx92-hxfolHX5qfvrTsmt2dv3y9VP1683aQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQIuiDeFBYzE1TQvP3KsKqoC2wqxrbQ3y0lsVJSmUZMguPA7-LmMHacsYtEiblHssa3xeDxjf55B6JXJOS1AdIi9KgEHhVOSZoYS2AzB3zI0zh02Z7Fk83Xy7pyeH6Hp8BbGwiq97u91utPW_s_Yc3NcbzbjM3upB_4VDUFIYy7YNXQ9geVr0xi8_n4B55G4aLu2NrHVh_dzDuQFwwf2WIQXd2E8_enKJfvT3-xPtw_N7qDb3oDEk36Md9GRru6hGwt_RX4f_VjX-z6_PHAc7wzeWsjdx-UE-MSx_uqBrxXOvuGzsvuEawfI0w1uu-1ujzfVF-XKVVXgrW4VmI_NprEtVbuKNFtVltge9-MS9ATOrdTs3Q9ooU_6g5uuPnQDdKvZ5EM0fYDWszer6Zz49AskpyxpSZGbPFUmEgo8aBNprQKjjQ6Y4CqjBcxkkaRZTnUE30oXPCrAegkVM1QIFmbxQ3QMA9OPEaZBoLmgTCUx-DtaZJyZVPBExxoazvQIxQPTZe5jk9sUGaUcQGifZT9V0k6VdFi8aITIgaruY3NcUZ8O8ymHd6egKSVsHlfQ8cvodOOXeyND2UQykH-I5EXK36T6H_o8GQRO_uomDdMEZJyKEXp5KAZ9YCdZVXrX2ToBuIgMrPgRetQL6oE5kbDB9Sl78t_DeoFuzleLU3n6dvn-KbplS-wBeyRO0HG77_QzsNDa7LlbgT8Bnic49w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+microRNA-137+expression+by+Slug+promotes+tumor+invasion+and+metastasis+of+non-small+cell+lung+cancer+cells+through+suppression+of+TFAP2C&rft.jtitle=Cancer+letters&rft.au=Chang%2C+Tzu-Hua&rft.au=Tsai%2C+Meng-Feng&rft.au=Gow%2C+Chien-Hung&rft.au=Wu%2C+Shang-Gin&rft.date=2017-08-28&rft.pub=Elsevier+B.V&rft.issn=0304-3835&rft.eissn=1872-7980&rft.volume=402&rft.spage=190&rft.epage=202&rft_id=info:doi/10.1016%2Fj.canlet.2017.06.002&rft.externalDocID=S0304383517303786 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3835&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3835&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3835&client=summon |